In this video, Matthew LeBlanc, PhD, RN, University of North Carolina, Chapel Hill, NC, shares some insights into the importance of measuring financial toxicity in multiple myeloma, highlighting various tools used to measure this. Dr LeBlanc also challenges the approach of using health-related quality of life (HRQoL) to measure financial toxicity, and further discusses factors to consider when bringing this into clinical practice. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.